Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. (FRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FRTX · as of Jun 9, 2026
Key Statistics
Explore Fresh Tracks Therapeutics, Inc. Data
frtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
frtx competitorsFRTX
APTO
BVXV
ENTO
NBRVF
NEUPStock Performance
Full HistoryAbout Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debi…
what is fresh tracks therapeutics, inc. · frtx stock overview · fresh tracks therapeutics, inc. company profile · who is fresh tracks therapeutics, inc. ceo · frtx NASDAQ · fresh tracks therapeutics, inc. headquarters · fresh tracks therapeutics, inc. business segments
About Stock Overview & Key Data
Fresh Tracks Therapeutics, Inc. (FRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 10, 1993. As of the latest trading session, FRTX stock price is $0.94, with a market capitalization of $5.6M. The stock has returned +3.88% over the past 12 months and +25.08% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Fresh Tracks Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Fresh Tracks Therapeutics, Inc. reported revenue of $8.0M and net income of -$5.7M. For detailed data — including Fresh Tracks Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fresh Tracks Therapeutics, Inc. (FRTX) stock price is $0.94. The stock is traded on NASDAQ under the ticker symbol FRTX. The 52-week range is $0.03 – $1.03.